Journal Information
Vol. 10. Issue 53.
Pages 81-90 (March - April 1996)
Vol. 10. Issue 53.
Pages 81-90 (March - April 1996)
Open Access
La publicidad de los medicamentos: ¿riesgo o beneficio?
Drug advertisement: risk or benefit?
Visits
4584
J.A.C. Barros*
Universidade Federal de Pernambuco. Núcleo de Estudos de Saúde (NESC), Recife/PE
This item has received

Under a Creative Commons license
Article information
Resumen

Ya está suficientemente comprobada la importancia del rol asignado al médico en el consumo de los medicamentos. A partir de su condición de intermediario de la adquisición y dispensación de medicamentos, el prescriptor es la gran diana de las actividades promocionales de los productores, orientadas hacia la optimización de las ganancias aunque bajo el disfraz del propósito de educar y/o informar. Diferentes estudios evidenciaron el lugar destacado ocupado por las fuentes comerciales sobre la prescripción. La presente revisión enfatiza dos de estas fuentes -los anuncios en revistas y el visitador médico-concluyendo a partir de múltiples estudios que los primeros en general presentan informaciones sesgadas o incompletas mientras que el segundo cumple el papel de mero agente de ventas. Se presentan igualmente las fuentes profesionales de información y los alcances y límites de dos de ellas: las guías farmacológicas y los boletines terapéuticos.

Palabras clave:
Publicidad farmacéutica
Información sobre medicamentos
Influencias sobre la prescripción
Summary

It is obvious how important is the role of the physicians on drugs consumption. On account of theirintermediation in the procurement and consumption of medicines, the prescriber is the main focus of manufacturers' promotional activities aiming at increasing sales and profits although these activities often are disguised as a means of education or information. Many reports have been issued emphasizing the influence of commercial sources upon the prescription. This text reviews two of them -advertisements in medical journals and the representatives-arriving to the conclusion that first ones display informations that are biased and incomplete while the representative in fact acts as a sales agent. The professional sources of information for prescribers are also described being evaluated howfa -reaching the sources referred can be.

Key words:
Pharmaceutical advertisements
Information on drugs
Influences upon prescription
Full text is only aviable in PDF
Bibliografía
[1.]
J.A.C. Barros.
Medicalización y salud.
Cuadernos médico sociales, 28 (1984), pp. 25-31
[2.]
J.A.C. Barros.
¿Hay que preocuparse por los efectos indeseables de los fármacos?.
Cuadernos médico sociales, 62 (1992), pp. 17-24
[3.]
J. Baudrillard.
Crítica de la economía política del signo.
[4.]
I. Illich.
Némesis médica.
[5.]
C. Medawar.
Power and dependence. Social Audit on the safety of medicines.
[6.]
R. Taylor.
Medicine outof contro. The anatomy of a malignant technology.
[7.]
J.A.C. Barros.
Estrategias de marketing de la industria farmacéutica: una aproximación al estudio del problema en Recife/Brasil [tesis doctoral].
[8.]
F. Capra.
El punto crucial.
[9.]
F. Lefèvre.
O medicamento como mercadoria simbolica.
[10.]
C.W.M. Wilson.
Influence of different sources of therapeutic information on prescribing by general practitiones.
Br Med J, ii (1963), pp. 599-604
[11.]
J. Coleman.
Social processes in physicians’ adoption of a new drug.
J Chron Dis, 9 (1959), pp. 1-18
[12.]
F.M. Haaijer-Buaskamp, E. Hemminki.
Social aspects of drug use.
pp. 97-124
[13.]
C.W.M. Wilson, et al.
Pattern of prescribing in general practice.
Br Med J, ii (1963), pp. 604-607
[14.]
P.D. Stolley, L. Lasagna.
Prescribing patterns of physicians.
J Chron Dis, 22 (1969), pp. 395-405
[15.]
C. Muller.
Medial review of prescribing.
J Chron Dis, 18 (1965), pp. 689-696
[16.]
C.W. Gowdey, R.W. Fasold.
Survey of doctors' reaction to the promotion of new drugs.
Can Pharm J, 30 (1968), pp. 344-350
[17.]
J.C. Gerez.
Indùstria Farmacèutica: histórico, mercado e competigao.
Ciència Hoje, 15 (1993), pp. 21-30
[18.]
J.l. Mackowiak, J.P. Gagnon.
Effects of promotion on pharmaceutical demand.
Soc Sci Med, 20 (1985), pp. 1191-1197
[19.]
HAI (Health Action International) Promoting health or pushing drugs?.
A critical examination of marketing of pharmaceuticals.
[20.]
Comissào Parlamentar de Inquérito da Indùstria Farmacèutica.
Diàrio do Congresso Nacional, 139 (1980),
[21.]
E. Hemminki, T. Pesonen.
A inquiry into associations between leading physicians and the drug industry.
Soc Sci med, 11 (1977), pp. 501-506
[22.]
J.M. Arnau.
Promoción del uso racional de los medicamentos y preparación de guías farmaco ógicas.
Principios de epidemiología del medicamento, 2a ed, pp. 49-63
[23.]
M.S. Wilkes, B.H. Doblin, M.F. Shapiro.
Pharmaceutical advertisements in leading medical journals: experts' assessment.
Ann Int Med, 116 (1992), pp. 912-919
[24.]
WHO.
Ethical criteria for medicinal drug promotion.
[25.]
Anónimo.
Pharma promotiom-WHA reflects CIOMS consensus.
Scrip, (1994), pp. 22-23
[26.]
A. Herxheimer, C.S. Lundborg, B. Westrholm.
Advertisements for medicines in leading medical journals in 18 countries: A12-month survey of information content and standards.
Int J Health Serv, 23 (1993), pp. 161-172
[27.]
cols Valpuesta y.
Análisis de la publicidad medicamentosa en revistas médicas no especializadas.
Rev Clin Esp, 192 (1993), pp. 130-133
[28.]
Hevia A y cois.
Muestreo de la publicidad de la industria quimicofarmacéuticaen revistas pediátricas.
RevFarmaco!Clin Exp, 7 (1990), pp. 99-104
[29.]
G. Tomson, K. Weerasuriya.
“Codes” and practice: Information in drug advertisements. An example from Sri Lanka.
Soc Sci Med, 31 (1990), pp. 737-741
[30.]
J.H. Goldstein.
Of mugs and marketing.
JAMA, 265 (1991), pp. 2391-2392
[31.]
F. Lobo.
Estructuras monopolísticas y publicidad: el sistema de desinformación farmacéutica.
Revista Española de Investigaciones Sociológicas, 5 (1979), pp. 81-117
[32.]
D. Rennie.
Editors and advertisements: What responsibility do editors have for the advertisements in their journals?.
JAMA, 265 (1991), pp. 2394-2396
[33.]
Anonimo.
FDA crackdown on video news releases.
Scrip, (1991), pp. 17
[34.]
J. Lexchin.
Doctors and detailers: Therapeutic education or pharmaceutical promotion?.
Int J Health Serv, 19 (1989), pp. 663-679
[35.]
Anonimo.
Effectiveness of UK pharma reps.
Scrip, (1991), pp. 4
[36.]
D.B. Christensen.
Bush. Drug prescribing: patterns, problems and proposals.
Soc Sci Med, 15 (1981), pp. 343-355
[37.]
G. Peters.
Information and education about drugs. En: Pharmaceutical and health policy -International perspectives on provision and control of medicines.
pp. 93-121
[38.]
E. Hemminki.
Content analysis of drug detailing by pharmaceutical representatives.
Med Education, 11 (1977), pp. 210-215
[39.]
R. Blum, et al.
Pharmaceutical and health policy-International perspectives on provision and control of medicines.
[40.]
E. Hemminki.
The function of drug company representatives.
Scand J Soc Med, 5 (1977), pp. 105-114
[41.]
E. Hemminki.
Commercial information on drugs. Confusing the physician?.
J Drug Issues, 18 (1988), pp. 245-257
[42.]
R.W. Bell, J.W. Osterman.
The Compendium of pharmaceuticals and specialties: A critical analysis.
IntJ Health Services, 13 (1983), pp. 107-118
[43.]
A. Herxheimer.
Drug bulletin as part of the scientific literature.
Current Contents, (1991),
[44.]
C.G. Berbatis.
Impact of a Drug Bulletin on Prescribing Oral Analgesics in a Teaching Hospital.
Am J Hosp Pharm, 39 (1982), pp. 98-100
[45.]
R.R.J. Plumridge, C.G. Berbatis.
Drug bulletins: Effectiveness in modifying prescribing and methods of improving impact.
Annals of Pharmacotherapy, 23 (1989), pp. 330-334
[46.]
U.S. Congress, Office of Technology Assessment.
Drug labeling in developing countries, OTA-H-464.
[47.]
International Federation of Pharmaceutical Manufacturers Associations. IFPMA code of Pharceutical Marketing Practices. Geneva: IFPMA
[48.]
HAI (Health Action International) An international code of pharmaceutical marketing practice -Adiscussion documental.
HAI Europe, Amsterdam, (1992),
[49.]
Anonimo.
UK code of practice breaches.
Scrip, (1990), pp. 2
[50.]
A. Herxheimer, J. Collier.
Promotion by the British pharmaceutical industry, 1983-8: a critical analysis of self regulation.
Br Med J, 300 (1990), pp. 307-311
[51.]
D.A. Kessler.
Addressing the problem of misleading advertising.
Ann Int Med, 116 (1992), pp. 950-951
Copyright © 1996. Sociedad Española de Salud Pública y Administración Sanitaria
Download PDF
Idiomas
Gaceta Sanitaria
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?